Leveragen, Inc.
PrivateLast Round
Strategic
Jul 25, 2025
Company Overview
Leveragen, Inc. is a biotechnology company that provides customized genetic modeling services and proprietary antibody discovery platforms for pharmaceutical and biotechnology partners.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Leveragen, Inc. Comparables
Compare Leveragen, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbTherx, Inc. | 85% | |
| Alloy Therapeutics | 79% | |
| Twist Bioscience Corporation | 77% | |
Leveragen, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jul 25, 2025 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Monthly visitors increased 54% MoM.
- Jan 31, 2026
Monthly visitors increased 51% MoM.
Leveragen, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Leveragen, Inc.'s valuation, stock price, and market status.